Essex Financial Services, Inc. Amgen Inc Transaction History

Essex Financial Services, Inc.

$1.36 Billion
Q4 2024

A detailed history of Essex Financial Services, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Essex Financial Services, Inc. holds 5,199 shares of AMGN stock, worth $1.48 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

5,199

Previous 4,878 6.58%

Holding current value

$1.48 Million

Previous $1.57 Million 13.75%

% of portfolio

0.1%

Previous 0.08%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 29, 2025	BUY	$258.78 - $328.31 $83,068 - $105,387	321 Added 6.58%	5,199 $1.36 Million
Q3 2024 Oct 24, 2024	SELL	$309.38 - $337.38 $576,065 - $628,201	-1,862 Reduced 27.63%	4,878 $1.57 Million
Q2 2024 Aug 09, 2024	BUY	$262.75 - $319.31 $16,027 - $19,477	61 Added 0.91%	6,740 $2.11 Million
Q2 2024 Jul 31, 2024	BUY	$262.75 - $319.31 $180,509 - $219,365	687 Added 11.47%	6,679 $2.09 Million
Q1 2024 Apr 23, 2024	SELL	$268.87 - $324.56 $27,155 - $32,780	-101 Reduced 1.66%	5,992 $1.7 Million
Q4 2023 Feb 05, 2024	SELL	$255.7 - $288.46 $41,679 - $47,018	-163 Reduced 2.61%	6,093 $1.75 Million
Q3 2023 Nov 15, 2023	SELL	$218.65 - $271.46 $17,054 - $21,173	-78 Reduced 1.23%	6,256 $1.68 Million
Q2 2023 Aug 08, 2023	SELL	$214.27 - $253.37 $70,066 - $82,851	-327 Reduced 4.91%	6,334 $1.41 Million
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $74,510 - $90,816	330 Added 5.21%	6,661 $1.61 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $8,474 - $10,767	-37 Reduced 0.58%	6,331 $1.66 Million
Q3 2022 Nov 07, 2022	SELL	$224.46 - $253.15 $10,100 - $11,391	-45 Reduced 0.7%	6,368 $1.44 Million
Q2 2022 Aug 01, 2022	SELL	$230.71 - $256.74 $47,295 - $52,631	-205 Reduced 3.1%	6,413 $1.56 Million
Q1 2022 Apr 21, 2022	SELL	$219.27 - $242.57 $19,953 - $22,073	-91 Reduced 1.36%	6,618 $1.6 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $117,538 - $134,511	-591 Reduced 8.1%	6,709 $1.51 Million
Q3 2021 Nov 10, 2021	BUY	$212.27 - $248.7 $909,364 - $1.07 Million	4,284 Added 142.04%	7,300 $1.55 Million
Q1 2021 May 11, 2021	SELL	$221.91 - $258.6 $454,027 - $529,095	-2,046 Reduced 40.42%	3,016 $750,000
Q4 2020 Feb 05, 2021	BUY	$216.38 - $257.67 $22,287 - $26,540	103 Added 2.08%	5,062 $1.16 Million
Q3 2020 Nov 10, 2020	BUY	$234.65 - $260.95 $26,984 - $30,009	115 Added 2.37%	4,959 $1.26 Million
Q2 2020 Aug 06, 2020	SELL	$197.81 - $242.74 $5,934 - $7,282	-30 Reduced 0.62%	4,844 $1.14 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $930,517 - $1.23 Million	-5,106 Reduced 51.16%	4,874 $988,000
Q4 2019 Jan 30, 2020	BUY	$189.21 - $243.2 $11,163 - $14,348	59 Added 0.59%	9,980 $2.41 Million
Q3 2019 Nov 04, 2019	SELL	$174.11 - $208.62 $7.02 Million - $8.41 Million	-40,328 Reduced 80.26%	9,921 $1.92 Million
Q2 2019 Jul 30, 2019	BUY	$166.7 - $195.41 $91,685 - $107,475	550 Added 1.11%	50,249 $9.26 Million
Q1 2019 May 02, 2019	SELL	$180.87 - $203.88 $92,967 - $104,794	-514 Reduced 1.02%	49,699 $9.44 Million
Q4 2018 Feb 07, 2019	SELL	$178.4 - $208.25 $140,044 - $163,476	-785 Reduced 1.54%	50,213 $9.78 Million
Q3 2018 Nov 05, 2018	BUY	$185.29 - $208.89 $645,365 - $727,563	3,483 Added 7.33%	50,998 $10.6 Million
Q2 2018 Aug 07, 2018	BUY	$166.05 - $186.51 $102,784 - $115,449	619 Added 1.32%	47,515 $8.77 Million
Q1 2018 May 03, 2018	SELL	$169.43 - $198.0 $923,393 - $1.08 Million	-5,450 Reduced 10.41%	46,896 $8 Million
Q4 2017 Feb 07, 2018	SELL	$168.79 - $188.59 $25,318 - $28,288	-150 Reduced 0.29%	52,346 $9.1 Million
Q3 2017 Nov 03, 2017	SELL	$167.29 - $191.0 $34,127 - $38,964	-204 Reduced 0.39%	52,496 $9.79 Million
Q2 2017 Aug 07, 2017	BUY	N/A	52,700	52,700 $9.08 Million

Others Institutions Holding AMGN

# of Institutions

3,084

Shares Held

401M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $153B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Essex Financial Services, Inc. with notifications on news.

Account

Essex Financial Services, Inc. Amgen Inc Transaction History